FormDSignal

Pelthos Therapeutics Inc. (PTHS)

1 Item 5.02 filing since 2026-10-30 · roles: CEO. NYSE. Biological Products, (No Diagnostic Substances). State: NC.

ScoreFiledEventRolePersonSeatSummary
02026-10-30Compensation onlyCEOsubscribers—Pelthos Therapeutics Inc. (PTHS): CEO Scott Plesha compensation terms

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works